Abstract
Objectives Information on prevalence of face mask usage in response to SARS-CoV-2 is required to both model disease spread and to improve compliance with mask usage. We sought to (1) estimate the prevalence of mask usage in northern Vermont and to (2) assess the effect of age and sex on mask usage.
Methods We monitored the entrances to businesses and visually assessed individuals’ age, sex, and mask usage from a distance. We collected 1004 observations from 16 May through 30 May 2020 as businesses began to reopen following an extended state-wide lockdown. We analyzed these data using Bayesian random effects logistic regression.
Results 75.5% of individuals used a mask with significant effects of age and sex on mask usage. Females were more likely than males to wear masks (83.8%, n=488 vs. 67.6%, n=516); the odds of mask usage in males were 53% of those for females. Elders were most likely to wear a mask (91.4%, n=209) followed by young adults (74.8%, n=246), middle-aged adults (70.7%, n=519) and children (53.3%, n=30). The odds of an elder wearing a mask were 16.7 times that of a child, while the odds for young adults and middle-aged adults were ∼3 times greater than for a child. Highest mask usage was in elder females (96.3%, n=109) and lowest mask usage was in male children (43.8%, n=16).
Conclusions We found high prevalence of mask usage overall, but also large differences in mask usage with age and sex. Females and elders had the highest use of face masks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Vermont Research Protections Office granted our study an exemption from review by our institutional review board (CHRBSS (Behavioral): STUDY00001094).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* brian.beckage{at}uvm.edu
We added a middle initial to one of author's names. We replaced 'gender' with 'sex'. We added our university's IRB exemption number.
Data Availability
We have posted the data and code to a GitHub repository and will make these available publicly after the study has been published in a peer-reviewed journal.
